Search Results for: stem cell biotech

CIRM goes genomic

In June 2011 I did a post about genomics and its growing importance both for science and society. The stem cell field has a very rapidly accelerating genomic component as well. I went so far as to call it a revolution and I still believe that is not an exaggeration. CIRM has rightly recognized the …

CIRM goes genomic Read More »

What does Geron’s departure mean for ACT? Some perspectives

About two months about Geron shocked and disappointed the stem cell community by dropping its stem cell program. The move was reportedly made for financial, not scientific reasons. Biotech companies have to be financially sound in order to help stem cell researchers turn science into cures and Geron’s leadership had to do what it thought …

What does Geron’s departure mean for ACT? Some perspectives Read More »

The Scarlett letter? What the experts really think about Geron

The grapevine is afire with the Geron news and there are many interpretations out there of what it means and why it happened. Based on several accounts from folks who remain anonymous, here is the most probable prediction of what happened to lead us to yesterday’s announcement. Geron has been worried for a long time …

The Scarlett letter? What the experts really think about Geron Read More »

Bad news as Geron to quit hESC SCI trial for financial reasons

Geron-300x2212

Reportedly, Geron has decided to only focus on cancer research and for financial reasons has shut down its hESC trial for spinal cord injury. This is a very sad day for stem cell science. (Update in 2020: the firm still exists, but is working in different areas. The stock has struggled.) No more spinal cord …

Bad news as Geron to quit hESC SCI trial for financial reasons Read More »

The news of CIRM and clinical trial: don’t forget the patient

As much as so many were excited yesterday about the enrollment of the first patient in a CIRM-funded clinical trial, I did not see a mention of a very important element. The patient. Our excitement about the clinical trial moving forward is understandable, but we also need to keep a sober perspective on the fact …

The news of CIRM and clinical trial: don’t forget the patient Read More »

California pays its sports coaches alone more than the entire payroll of CIRM

CIRM-

There has been a largely media-fed hullabaloo about the salary for the new Chair of CIRM, the California Institute for Regenerative Medicine, $400,000. Now don’t get me wrong, that sounds like a lot of money to me personally, but we need to put it in perspective and when we do, the salary is reasonable and …

California pays its sports coaches alone more than the entire payroll of CIRM Read More »

And the new leader of CIRM is…

The CIRM Board is meeting today and will decide on its future Chair via an election. There are two candidates, Jonathan Thomas (nominated by Bill Lockyer, the California state treasurer) and Frank Litvack, nominated by state controller, John Chang. Thomas is described as a Bond financier, while Litvack is an L.A. cardiologist and businessman with …

And the new leader of CIRM is… Read More »

Report: CIRM creates 8 jobs a day for California

A report will be issued today of the economic impact of CIRM on California. The Sac Bee and FierceBiotech are reporting on the economic infusion that CIRM has provided to the state. On average during its existence, CIRM has created 8 jobs day for the state of California. The jobs mostly consist not surprisingly of …

Report: CIRM creates 8 jobs a day for California Read More »

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness

advanced-cell-technology

The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge …

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness Read More »